James Gilmore III, Insider at BARR PHARMACEUTICALS INC (BRL), sold 48,750 shares at $64.55 ($3.2M) on 2008-11-11, disclosed to the SEC on 2008-11-13.
Open-market sale of $3.2M BRL by Insider. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.55 | 6,957 | $449K | 14.2% |
| 2 | $64.56 | 500 | $32K | 1.0% |
| 3 | $64.57 | 100 | $6K | 0.2% |
| 4 | $64.60 | 15,050 | $972K | 30.8% |
| 5 | $64.61 | 500 | $32K | 1.0% |
| 6 | $64.65 | 100 |
| $6K |
| 0.2% |
| 7 | $64.66 | 600 | $39K | 1.2% |
| 8 | $64.67 | 200 | $13K | 0.4% |
| 9 | $64.67 | 400 | $26K | 0.8% |
| 10 | $64.68 | 200 | $13K | 0.4% |
| 11 | $64.68 | 4,100 | $265K | 8.4% |
| 12 | $64.69 | 200 | $13K | 0.4% |
| 13 | $64.70 | 1,700 | $110K | 3.5% |
| 14 | $64.70 | 2,000 | $129K | 4.1% |
| 15 | $64.71 | 200 | $13K | 0.4% |
| 16 | $64.72 | 100 | $6K | 0.2% |
| 17 | $64.72 | 743 | $48K | 1.5% |
| 18 | $64.73 | 543 | $35K | 1.1% |
| 19 | $64.73 | 1,157 | $75K | 2.4% |
| 20 | $64.74 | 100 | $6K | 0.2% |
| 21 | $64.74 | 1,000 | $65K | 2.1% |
| 22 | $64.75 | 11,700 | $758K | 24.0% |
| 23 | $64.75 | 500 | $32K | 1.0% |
| 24 | $64.76 | 100 | $6K | 0.2% |
| Total | $64.66 avg | 48,750 | $3.2M | 100% |
| Filing → |
| AAWW | SELL | 2017-03-01 | $447K | — | Filing → |
| CACI | SELL | 2011-03-15 | $12K | — | Filing → |
| CACI | SELL | 2010-12-02 | $17K | — | Filing → |